Heart

Papers
(The H4-Index of Heart is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis193
Prevalence, incidence and survival of heart failure: a systematic review128
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure101
Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China101
Diagnosis, management and therapeutic strategies for congenital long QT syndrome96
Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management93
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK90
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank80
Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities77
Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 201764
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis61
Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges59
Cardiac sarcoidosis: state-of-the-art review54
Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation54
Arrhythmogenic left ventricular cardiomyopathy53
Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis51
Systematic review of current natural language processing methods and applications in cardiology51
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry49
Recreational substance use among patients with premature atherosclerotic cardiovascular disease48
Sacubitril/valsartan in the treatment of systemic right ventricular failure44
Artificial intelligence for the echocardiographic assessment of valvular heart disease43
Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial43
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis43
Contrast-enhanced computed tomography assessment of aortic stenosis43
Cardiotoxicities of novel cancer immunotherapies41
Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic40
Cardiac myxomas: clinical presentation, diagnosis and management39
Association of physical activity trajectories with major cardiovascular diseases in elderly people38
Parameters associated with ventricular arrhythmias in mitral valve prolapse with significant regurgitation38
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic37
Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models36
Lipoprotein(a) is robustly associated with aortic valve calcium36
The effect of green Mediterranean diet on cardiometabolic risk; a randomised controlled trial36
Physical activity and the progression of coronary artery calcification35
Risks and benefits of percutaneous coronary intervention in spontaneous coronary artery dissection35
0.41674613952637